Events

The Southwest SELPA "Best Practices in Autism" conference presents a lecture on

Update on Medication, Treatment of PDD

Principal Investigator, CART SSRI Treatment Project
Joseph Campbell Professor and Director
Division of Child and Adolescent Psychiatry
UCLA Neuropsychiatric Institute and Hospital in Los Angeles
David Geffen School of Medicine at UCLA
Assistant Professor, UCLA Neuropsychiatric Institute

Friday, 10 March 2006
1:00 - 2:00 PM

Over the past 5 years or so, the results of a new generation of research studies testing the safety and benefits of a variety of medications for PDD have emerged. Most of the newer studies have been designed to target a particular constellation of symptoms, such as agitation and aggression, and this approach appears to have been fruitful. As some successes have been documented, some safety concerns have also appeared which will be reviewed. Lastly, some experimental data on the use of genetics to predict treatment outcomes will be presented. Given the growth of new data, it is important for both parents and practitioners to be up-to-date with current findings.

The lecture will be held at the Hilton Hotel Southbay on Hawthorne Blvd in Torrance.
For information on how to register for this conference, and more information on the program, click here.